In this article, we will take a look at the 10 stocks on investors’ radar after earnings reports.
Notable stocks from the healthcare, consumer cyclical, and technology sectors, including Pfizer Inc. (NYSE:PFE), Amgen Inc. (NASDAQ:AMGN), Peloton Interactive, Inc. (NASDAQ:PTON) and Fiserv, Inc. (NASDAQ:FISV), recently came out with their earnings reports.
If we look at their price action, shares of Pfizer and Fiserv turned red after missing sales expectations for their respective quarters, while Amgen stock jumped to a nearly six-month high after posting upbeat results.
On the other hand, Peloton stock climbed over 25 percent despite its weak financial performance. However, the surge apparently followed multiple reports that Amazon and Nike are interested in buying Peloton.
Several other companies, including Hasbro, Inc. (NASDAQ: HAS), Tyson Foods, Inc. (NYSE:TSN) and DuPont de Nemours, Inc. (NYSE:DD), also came into the limelight after releasing their financial results.
Now, let’s discuss the detailed performance of these companies.
Stocks On Investors’ Radar After Earnings Reports
10. Rambus Inc. (NASDAQ:RMBS)
Number of Hedge Fund Holders: 21
Shares of Rambus Inc. (NASDAQ:RMBS) jumped nearly five percent on Tuesday, February 8, 2022, despite posting mixed financial results for the fourth quarter. The tech company generated revenue of $91.8 million, below the consensus estimate of $121.52 million.
On the bright side, Rambus Inc. earned 39 cents per share on an adjusted basis, beating analysts’ average estimate of 37 cents per share. Among other updates, the company said that cash from operating activities came in at $72.2 million for the quarter.
Rambus Inc. also released its segment-wise sales outlook for the first quarter. It expects product revenue in the range of $43 – $49 million, royalty revenue of $30 – $36 million and contract and other revenue between $12 – $18 million.
Speaking on the results, CEO Luc Seraphin said:
“Rambus delivered an outstanding fourth quarter contributing to an exceptionally good year, driven by excellent execution and record product revenue. The record cash generation fuels our ongoing strategic investment in scaling the business, returning value to stockholders, and extending our product roadmap to enable continued profitable growth.”
9. Axcelis Technologies, Inc. (NASDAQ:ACLS)
Number of Hedge Fund Holders: 22
Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) rose more than six percent on Tuesday, February 8, 2022, after the components manufacturer for the semiconductor industries announced better-than-expected financial results for the fourth quarter.
Axcelis Technologies, Inc. reported earnings of $1.05 per share, significantly higher than 43 cents per share in the year-ago period. Analysts were looking for earnings of 84 cents per share.
In addition, the company posted revenue of $205.7 million, compared to $122.2 million for the fourth quarter of 2020 and above expectations of $190 million. Looking forward, Axcelis Technologies, Inc. expects revenue of around $193 million for the first quarter.
Like Axcelis Technologies, Inc., investors are also closely watching Pfizer Inc., Amgen Inc. and Peloton Interactive, Inc., following their earnings reports.
8. Hasbro, Inc. (NASDAQ: HAS)
Number of Hedge Fund Holders: 25
Shares of Hasbro, Inc. turned red on Monday, February 7, 2022, even after announcing its profit and sales for the fourth quarter above expectations. The results were helped by a recovery in its television production unit and higher sale of toys related to the latest Spider-Man sequel.
Hasbro, Inc. earned $1.21 per share on an adjusted basis, crushing the consensus expectations of 88 cents per share. Revenue for the quarter jumped 17 percent on a year-over-year basis to $2.01 billion, surpassing analysts’ average estimate of $1.87 billion.
If we look at the company’s segment-wise sales performance, revenue from the entertainment division climbed 54 percent, revenue from the wizards of the coast and digital gaming segment rose 18 percent, and revenue from the consumer products segment increased 9 percent in the quarter.
Hasbro, Inc. also released its sales outlook for 2022. The toymaker expects its revenue to grow in a low-single-digit percentage.
7. Tyson Foods, Inc. (NYSE:TSN)
Number of Hedge Fund Holders: 33
Shares of Tyson Foods, Inc. recently climbed to an all-time high after posting solid profit and sales for its fiscal first quarter. The company benefitted from soaring meat prices and strong demand for its beef, pork and chicken during the quarter.
Tyson Foods, Inc. reported adjusted earnings of $2.87 per share, up 48 percent versus the year-ago period. Revenue for the quarter increased to $12.93 billion, compared to $10.46 billion in the same period last year.
Analysts were expecting Tyson Foods, Inc. to post earnings of $1.90 per share on revenue of $12.18 billion. Looking forward, the company expects its fiscal 2022 revenue to come at the higher end of its previous outlook of $49 – $51 billion.
Like Tyson Foods, Inc., Pfizer Inc., Amgen Inc. and Peloton Interactive, Inc., also came into the spotlight after their financial results.
6. Centene Corporation (NYSE:CNC)
Number of Hedge Fund Holders: 50
Shares of Centene Corporation (NYSE:CNC) hit a new 52-week high of $86.01 on Tuesday, February 8, 2022, after the Missouri-based healthcare company announced better-than-expected financial results for the fourth quarter.
Centene Corporation earned $1.01 per share on an adjusted basis, more than double from 46 cents per share in the comparable period of 2020. Analysts were looking for earnings of 98 cents per share.
In addition, Centene Corporation posted revenue of $32.6 billion, up 15 percent versus last year and just ahead of the consensus forecast of $32.5 billion. Revenue from its flagship premium and services segment rose 15 percent to $30.5 billion in the quarter.
Centene Corporation also released its financial outlook for 2022. It expects adjusted earnings in the range of $5.30 – $5.50 per share and revenue between $135.9 – $137.9 billion for the current fiscal year. The guidance is in line with the consensus forecast of $5.44 per share for earnings and $135.9 billion for revenue.
Discussing the results, CEO Michael Neidorff said in a statement:
“We ended 2021 with strong fourth quarter results at the high end of our previously provided earnings guidance range. Our portfolio is performing well as we executed across our three major product lines, building on our strong foundation and extending our market-leading position in government sponsored healthcare.”
5. DuPont de Nemours, Inc. (NYSE:DD)
Number of Hedge Fund Holders: 51
Shares of DuPont de Nemours, Inc. rose over six percent on Tuesday, February 8, 2022, after delivering impressive profit and sales for the fourth quarter. The company reported adjusted earnings of $1.08 per share, up 54 percent versus last year.
Revenue for the quarter also surged 14 percent on a year-over-year basis to $4.3 billion. Analysts were expecting DuPont de Nemours, Inc. to post earnings of 99 cents per share on revenue of $4.03 billion.
DuPont de Nemours, Inc. also released its segment-wise sales performance. Its electronics and industrial revenue jumped 19 percent to $1.5 billion, water and protection revenue advanced 16 percent to $1.4 billion and mobility and materials revenue increased 12 percent to $1.3 billion in the quarter.
Looking forward, DuPont de Nemours, Inc. expects adjusted earnings in the range of $4.60 – $4.90 per share and revenue between $17.4 – $17.8 billion for the current fiscal year.
Discussing the results, CEO Ed Breen said in a statement:
“Sustained strong demand in key end-markets such as electronics and water, along with our continued ability to offset raw material inflation with price, were critical to our fourth quarter results.”
4. Amgen Inc. (NASDAQ:AMGN)
Number of Hedge Fund Holders: 52
Shares of Amgen Inc. climbed to a nearly six-month high on Tuesday, February 8, 2022, after announcing a better-than-expected profit for the fourth quarter. The California-based biopharmaceutical company earned $4.36 per share on an adjusted basis, topping estimates of $4.04 per share.
On the downside, Amgen Inc. generated revenue of $6.85 billion, slightly below analysts’ average estimate of $6.87 billion. The latest quarterly revenue was mainly driven by its Covid-19 manufacturing partnership with Eli Lilly.
Amgen Inc. also updated its sales outlook for 2022. It expects revenue in the range of $25.4 – $26.5 billion for the current year. This compares to analysts’ average estimate of $27 billion.
Speaking on the results, CEO Robert Bradway said:
“We realized strong volume growth for many of our key products during last year. These products, combined with our many pipeline opportunities, position us well for long-term growth.”
3. Peloton Interactive, Inc. (NASDAQ:PTON)
Number of Hedge Fund Holders: 62
Peloton Interactive, Inc. recently announced weak financial results for its fiscal second quarter. However, its shares jumped over 25 percent on Tuesday, February 8, 2022, despite the disappointing performance. Many attributed the latest surge to rumors that e-commerce giant Amazon and sportswear company Nike might be interested in buying Peloton.
Coming back to the latest financial results, Peloton Interactive, Inc. posted a loss of $1.39 per share, compared to earnings of 18 cents per share in the year-ago period. Revenue for the quarter increased 6 percent on a year-over-year basis to $1.13 billion. Analysts were looking for a loss of $1.20 per share on revenue of $1.15 billion.
If we look at the important growth drivers, the company’s connected fitness subscribers climbed 66 percent to 2.77 million in the quarter, while total members increased to more than 6.6 million. In addition, Peloton Interactive, Inc. reported that its paid digital subscribers jumped 28 percent versus last year to 862,000 in the quarter.
Among other updates, Peloton Interactive, Inc. announced that CEO John Foley would be replaced by former Spotify’s CFO, Barry McCarthy. The company also announced plans of trimming nearly 2,800 jobs worldwide amid weak demand for its products.
2. Fiserv, Inc. (NASDAQ:FISV)
Number of Hedge Fund Holders: 65
Shares of Fiserv, Inc. turned red on Tuesday, February 8, 2022, after announcing mixed financial results for the fourth quarter. The Wisconsin-based fintech company reported adjusted earnings of $1.57 per share, up 21 percent on a year-over-year basis.
In addition, Fiserv, Inc. posted an adjusted revenue of $4.02 billion, compared to $3.62 billion for the comparable period of 2020. Analysts had projected earnings of $1.56 and revenue of $4.03 billion.
Fiserv, Inc. also released its financial outlook for 2022. It expects adjusted earnings in the range of $6.40 – $6.55 per share and organic revenue growth between 7 – 9 percent for the current year.
Discussing the results, CEO Frank Bisignano said:
“For 2021, Fiserv had another successful year of delivering on our growth agenda – attaining the high end of our original organic revenue growth outlook and coming in well above our original adjusted EPS outlook, all while investing in the business to fuel further growth as we innovate to provide value for our clients.”
1. Pfizer Inc. (NYSE:PFE)
Number of Hedge Fund Holders: 74
Pfizer Inc. recently announced a better-than-expected profit for the fourth quarter. However, its quarterly sales fell below expectations, sending its shares down nearly three percent on Tuesday, February 8, 2022.
The New York-based pharmaceutical giant earned $1.08 per share on an adjusted basis, representing a surge of more than two folds versus the year-ago period. It also crushed the consensus forecast of 87 cents per share.
Revenue for the quarter also skyrocketed 105 percent on a year-over-year basis to $23.84 billion, mainly driven by sales of its coronavirus vaccine. However, analysts were expecting Pfizer Inc. to generate revenue of $24.16 billion
Looking forward, Pfizer Inc. expects adjusted earnings in the range of $6.35 – $6.55 per share and revenue between $98 – $102 billion for 2022. But the outlook fell short of analysts’ average estimate of $6.71 per share for earnings and $103.2 billion for revenue.
Speaking on the results, CFO of Pfizer Inc., Frank D’Amelio,, said in a statement:
“As I prepare to retire as CFO of Pfizer, I am proud to see that the company is performing better than at any other time during my nearly 15 years here. Today we are issuing guidance for the coming year which, if achieved, would represent the highest level of annual revenues and Adjusted diluted EPS in Pfizer’s long history.”
You can also take a peek at Early Retirement Portfolio: 15 Stocks to Live Off Dividends and Top 10 Stock Picks of Thomas Bancroft’s Makaira Partners.
Follow Insider Monkey on Twitter
Suggested articles:
- Top 10 Stock Picks of Prescott Group Capital Management
- 10 Dividend Aristocrats with Over 3% Yield
- 10 High Yield REIT Dividend Stocks For 2022
This article is originally published at Insider Monkey.
